Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06761482
NA

Non-Invasive Monitoring of Pediatric Kidney Transplant Recipients and Immunosuppression Personalization: an Open-labeled Multicenter Randomized Controlled Study

Sponsor: Assistance Publique - Hôpitaux de Paris

View on ClinicalTrials.gov

Summary

Currently, the monitoring of children receiving a kidney transplantation includes surveillance biopsies to detect subclinical rejection and signs of toxicity of immunosuppressive drugs (tacrolimus). The hypothesis of the study is that the combination of non-invasive biomarkers (Donor-derived cell-free DNA and Virus-specific T cells) will allow both the safe discontinuation of surveillance biopsies and the personalization of the exposure to calcineurin inhibitors among pediatric kidney transplant recipients.

Key Details

Gender

All

Age Range

1 Year - 21 Years

Study Type

INTERVENTIONAL

Enrollment

160

Start Date

2025-03-01

Completion Date

2029-03-01

Last Updated

2025-01-07

Healthy Volunteers

No

Interventions

PROCEDURE

monitoring by dd-cfDNA

monitoring by dd-cfDNA

PROCEDURE

monitoring by T-Vis

monitoring by T-Vis

PROCEDURE

monitoring by dd-cfDNA+ T-Vis

monitoring by dd-cfDNA+ T-Vis

Locations (1)

Robert Debré Hospital

Paris, France